The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)

被引:32
|
作者
Sznitowska, Malgorzata [1 ]
Wolska, Eliza [1 ]
Baranska, Helena [1 ]
Cal, Krzysztof [1 ]
Pietkiewicz, Justyna [1 ]
机构
[1] Med Univ Gdansk, Dept Pharmaceut Technol, Al Gen J Hallera 107, PL-80416 Gdansk, Poland
关键词
Solid lipid nanoparticles; Microparticles; Surfactants; Lipids; Ultrasound; NANOPARTICLES SLN; CYCLOSPORINE-A; FORMULATION; NLC; CRYSTALLIZATION; CLOTRIMAZOLE; DELIVERY; CARRIERS; DESIGN; MATRIX;
D O I
10.1016/j.ejpb.2016.10.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid lipid microparticles (SLM) were produced by a two-step process that, firstly, involved the emulsification of the molten lipid phase in a heated aqueous phase and, secondly, the system cooling. Compritol 888 ATO and Precirol ATO 5, including their mixtures with Miglyol 812 or Witepsol H15 were used as lipid components (10-30% w/w). The average size of the SLM prepared with Compritol and Tween 80 as an emulsifier was 3-7 mu m and the influence of lipid concentration and thermal sterilization was not large. Dispersions of SLM with Precirol (10-20% w/w) gellified upon storage. SLM stabilized with another surfactant, Tego Care 450, were larger in size and measured 40 mu m on average. The use of the sonication step (5-15 min) in hot formulations containing 5% w/w of Compritol resulted in the formation of the solid lipid nanoparticles (SLN) with average size 200-300 nm. The smallest SLN size (below 100 nm on average) was obtained in SLN that contained Tego Care and an antimicrobial agent Euxyl PE 9010; such combination evoked synergism between the surfactant and Euxyl components. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 50 条
  • [1] Effect of Surfactant on Characteristics of Solid Lipid Nanoparticles (SLN)
    Kullavadee, Karn-orachai
    Uracha, Ruktanonchai
    Smith, Siwaporn Meejoo
    [J]. NANOMATERIALS: SYNTHESIS AND CHARACTERIZATION, 2012, 364 : 313 - +
  • [2] Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)
    Zara, GP
    Cavalli, R
    Fundarò, A
    Bargoni, A
    Caputo, O
    Gasco, MR
    [J]. PHARMACOLOGICAL RESEARCH, 1999, 40 (03) : 281 - 286
  • [3] Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)
    Helgason, T.
    Awad, T. S.
    Kristbergsson, K.
    McClements, D. J.
    Weiss, J.
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2009, 334 (01) : 75 - 81
  • [4] Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel
    Miglietta, A
    Cavalli, R
    Bocca, C
    Gabriel, L
    Gasco, MR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 210 (1-2) : 61 - 67
  • [5] Solid lipid nanoparticles (SLN) -: Effects of lipid composition on in vitro degradation and in vivo toxicity
    Weyhers, H.
    Ehlers, S.
    Hahn, H.
    Sout, E. B.
    Mueller, R. H.
    [J]. PHARMAZIE, 2006, 61 (06): : 539 - 544
  • [6] Surfactant effect on the physicochemical characteristics of cationic solid lipid nanoparticles
    Botto, Chiara
    Mauro, Nicole
    Amore, Erika
    Martorana, Elisabetta
    Giammona, Gaetano
    Bondi, Maria Luisa
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 516 (1-2) : 334 - 341
  • [7] Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition
    Martins, S.
    Tho, I.
    Ferreira, D. C.
    Souto, E. B.
    Brandl, M.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2011, 37 (07) : 815 - 824
  • [8] Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages
    Schöler, N
    Olbrich, C
    Tabatt, K
    Muller, RH
    Hahn, H
    Liesenfeld, O
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 221 (1-2) : 57 - 67
  • [9] Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages
    Schöler, N
    Hahn, H
    Müller, RH
    Liesenfeld, O
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) : 167 - 176
  • [10] The effect of formulation and concentration of cholesteryl butyrate solid lipid nanospheres (SLN) on NIH-H460 cell proliferation
    Ugazio, E
    Marengo, E
    Pellizzaro, C
    Coradini, D
    Peira, E
    Daidone, MG
    Gasco, MR
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 52 (02) : 197 - 202